MedPath

MAYO CLINIC

MAYO CLINIC logo
🇺🇸United States
Ownership
Subsidiary
Established
1889-01-01
Employees
10K
Market Cap
-
Website
http://www.mayoclinic.org

Use of Pyridostigmine for Constipation in Diabetics

Phase 1
Completed
Conditions
Constipation
Diabetes Mellitus
Colonic Transit
Gastric Emptying
Interventions
First Posted Date
2006-01-13
Last Posted Date
2012-11-30
Lead Sponsor
Mayo Clinic
Target Recruit Count
30
Registration Number
NCT00276406
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin

Phase 2
Terminated
Conditions
Breast Pain
Non-cyclical Mastalgia
Surgical Scar-Related Breast Pain
Interventions
Drug: Placebo
First Posted Date
2006-01-13
Last Posted Date
2012-12-20
Lead Sponsor
Mayo Clinic
Target Recruit Count
25
Registration Number
NCT00276419
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes

Phase 4
Completed
Conditions
Type 1 Diabetes
First Posted Date
2006-01-13
Last Posted Date
2011-05-23
Lead Sponsor
Mayo Clinic
Target Recruit Count
22
Registration Number
NCT00276393
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.

Phase 4
Completed
Conditions
Unstable Angina
Non-ST-Elevation Myocardial Infarction
First Posted Date
2006-01-13
Last Posted Date
2010-01-28
Lead Sponsor
Mayo Clinic
Target Recruit Count
350
Registration Number
NCT00276432
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

First Posted Date
2006-01-12
Last Posted Date
2011-12-08
Lead Sponsor
Mayo Clinic
Target Recruit Count
165
Registration Number
NCT00275535
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

Phase 3
Completed
Conditions
Blood Stem Cell Transplant
First Posted Date
2006-01-12
Last Posted Date
2010-06-03
Lead Sponsor
Mayo Clinic
Target Recruit Count
15
Registration Number
NCT00275678
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.

Completed
Conditions
Kidney Transplant
First Posted Date
2006-01-12
Last Posted Date
2010-12-22
Lead Sponsor
Mayo Clinic
Target Recruit Count
60
Registration Number
NCT00275717
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis

Phase 1
Completed
Conditions
Glomerulonephritis, Membranoproliferative
Interventions
First Posted Date
2006-01-12
Last Posted Date
2013-01-16
Lead Sponsor
Mayo Clinic
Target Recruit Count
10
Registration Number
NCT00275613
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Topical Steroid Treatment for Eosinophilic Esophagitis

Phase 2
Completed
Conditions
Eosinophilic Esophagitis
Interventions
Drug: Placebo
First Posted Date
2006-01-12
Last Posted Date
2012-05-08
Lead Sponsor
Mayo Clinic
Target Recruit Count
42
Registration Number
NCT00275561
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

Phase 4
Completed
Conditions
Liver Transplant Recipients
First Posted Date
2006-01-12
Last Posted Date
2012-01-06
Lead Sponsor
Mayo Clinic
Target Recruit Count
62
Registration Number
NCT00275639
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath